Brand-name drug
Tegretol price, strengths & recalls
Brand of carbamazepine (generic)
Pharmacies pay $196.40 for 450 mL of Tegretol 20 mg/mL oral suspension this week, and from $48.79 to $196.40 across its 5 priced strengths and forms. The generic, carbamazepine, costs pharmacies from $3.58. It is in shortage (being discontinued). It has 14 recalls on record, none ongoing. Its official label last changed on August 21, 2026.
Being discontinuedBrand- Fair cash price
- $236.36
- Strengths
- 5
- Makers
- 1
- Updated
- Nov 11
Tegretol price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 mg (12 hr) extended-release tablet Brand | $1.63 | $48.79 / 30 tablets |
| 200 mg (12 hr) extended-release tablet Brand | $3.24 | $97.33 / 30 tablets |
| 400 mg (12 hr) extended-release tablet Brand | $6.49 | $194.71 / 30 tablets |
| 20 mg/mL oral suspension Brand | $0.4365 | $196.40 / 450 mL |
| 200 mg tablet Brand | $3.04 | $91.17 / 30 tablets |
The lowest cost per tablet is 100 mg (12 hr) extended-release tablet at $1.63. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Tegretol vs generic carbamazepine
Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:
| Strength | Brand | Generic | Brand costs |
|---|---|---|---|
| 100 mg (12 hr) extended-release tablet | $48.79 | $5.98 | 8.2x |
| 200 mg (12 hr) extended-release tablet | $97.33 | $11.38 | 8.6x |
| 400 mg (12 hr) extended-release tablet | $194.71 | $21.25 | 9.2x |
| 20 mg/mL oral suspension | $196.40 | $39.88 | 4.9x |
| 200 mg tablet | $91.17 | $3.58 | 25.5x |
Supply status: shortages & recalls
Shortages
- Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)Discontinuation of the manufacture of the drug
- Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)Discontinuation of the manufacture of the drug
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 14 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Tegretol
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
Tegretol
WARNINGS
SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE
SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-JOHNSON SYNDROME (SJS), HAVE BEEN REPORTED DURING TREATMENT WITH TEGRETOL. THESE REACTIONS ARE ESTIMATED TO OCCUR IN 1 TO 6 PER 10,000 NEW USERS IN COUNTRIES WITH MAINLY CAUCASIAN POPULATIONS, BUT THE RISK IN SOME ASIAN COUNTRIES IS ESTIMATED TO BE ABOUT 10 TIMES HIGHER. STUDIES IN PATIENTS OF CHINESE ANCESTRY HAVE FOUND A STRONG ASSOCIATION BETWEEN THE RISK OF DEVELOPING SJS/TEN AND THE PRESENCE OF HLA-B*1502, AN INHERITED ALLELIC VARIANT OF THE HLA-B GENE. HLA-B*1502 IS FOUND ALMOST EXCLUSIVELY IN PATIENTS WITH ANCESTRY ACROSS BROAD AREAS OF ASIA. PATIENTS WITH ANCESTRY IN GENETICALLY AT-RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH TEGRETOL. PATIENTS TESTING POSITIVE FOR THE ALLELE SHOULD NOT BE TREATED WITH TEGRETOL UNLESS THE BENEFIT CLEARLY OUTWEIGHS THE RISK (SEE WARNINGS AND PRECAUTIONS, LABORATORY TESTS).
APLASTIC ANEMIA AND AGRANULOCYTOSIS
APLASTIC ANEMIA AND AGRANULOCYTOSIS HAVE BEEN REPORTED IN ASSOCIATION WITH THE USE OF TEGRETOL. DATA FROM A POPULATION-BASED CASE CONTROL STUDY DEMONSTRATE THAT THE RISK OF DEVELOPING THESE REACTIONS IS 5 TO 8 TIMES GREATER THAN IN THE GENERAL POPULATION. HOWEVER, THE OVERALL RISK OF THESE REACTIONS IN THE UNTREATED GENERAL POPULATION IS LOW, APPROXIMATELY SIX PATIENTS PER ONE MILLION POPULATION PER YEAR FOR AGRANULOCYTOSIS AND TWO PATIENTS PER ONE MILLION POPULATION PER YEAR FOR APLASTIC ANEMIA.
ALTHOUGH REPORTS OF TRANSIENT OR PERSISTENT DECREASED PLATELET OR WHITE BLOOD CELL COUNTS ARE NOT UNCOMMON IN ASSOCIATION WITH THE USE OF TEGRETOL, DATA ARE NOT AVAILABLE TO ESTIMATE ACCURATELY THEIR INCIDENCE OR OUTCOME. HOWEVER, THE VAST MAJORITY OF THE CASES OF LEUKOPENIA HAVE NOT PROGRESSED TO THE MORE SERIOUS CONDITIONS OF APLASTIC ANEMIA OR AGRANULOCYTOSIS.
BECAUSE OF THE VERY LOW INCIDENCE OF AGRANULOCYTOSIS AND APLASTIC ANEMIA, THE VAST MAJORITY OF MINOR HEMATOLOGIC CHANGES OBSERVED IN MONITORING OF PATIENTS ON TEGRETOL ARE UNLIKELY TO SIGNAL THE OCCURRENCE OF EITHER ABNORMALITY. NONETHELESS, COMPLETE PRETREATMENT HEMATOLOGICAL TESTING SHOULD BE OBTAINED AS A BASELINE. IF A PATIENT IN THE COURSE OF TREATMENT EXHIBITS LOW OR DECREASED WHITE BLOOD CELL OR PLATELET COUNTS, THE PATIENT SHOULD BE MONITORED CLOSELY. DISCONTINUATION OF THE DRUG SHOULD BE CONSIDERED IF ANY EVIDENCE OF SIGNIFICANT BONE MARROW DEPRESSION DEVELOPS.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA020234 · Novartis
- First approved
- March 25, 1996 (30 years ago)
- Latest approved change
- July 15, 2026
- Approved label
- PDF, Jul 29, 2026
- Generic makers
- 26 approved generic applications on the market
Tegretol questions
How much does tegretol cost without insurance?
Pharmacies pay about $196.40 for 450 mL of tegretol 20 mg/mL oral suspension ($0.4365 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $236.36. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Tegretol?
Yes: carbamazepine. Pharmacies pay from $3.58 for it. Compare carbamazepine prices.
Is tegretol in shortage?
Yes. 3 products are listed as in shortage or being discontinued (being discontinued). See which ones.
Has tegretol been recalled?
14 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the tegretol label last change?
The official label was last updated on August 21, 2026 (version 39). See what changed.
Talk about tegretol
No comments yet. Questions, tips, what worked for you - start the conversation.